BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hahn A, Kim YJ, Kim HJ, Jang H, Cho H, Choi SH, Kim BC, Park KW, Na DL, Chin J, Seo SW. The preclinical amyloid sensitive composite to determine subtle cognitive differences in preclinical Alzheimer's disease. Sci Rep 2020;10:13583. [PMID: 32788669 DOI: 10.1038/s41598-020-70386-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Stricker NH, Twohy EL, Albertson SM, Karstens AJ, Kremers WK, Machulda MM, Fields JA, Jack CR Jr, Knopman DS, Mielke MM, Petersen RC. Mayo-PACC: A parsimonious preclinical Alzheimer's disease cognitive composite comprised of public-domain measures to facilitate clinical translation. Alzheimers Dement 2022. [PMID: 36565459 DOI: 10.1002/alz.12895] [Reference Citation Analysis]
2 Park J, Jang S, Gwak J, Kim BC, Lee JJ, Choi KY, Lee KH, Jun SC, Jang G, Ahn S. Individualized diagnosis of preclinical Alzheimer’s Disease using deep neural networks. Expert Systems with Applications 2022;210:118511. [DOI: 10.1016/j.eswa.2022.118511] [Reference Citation Analysis]
3 Kim J, Jung S, Choe YS, Kim S, Kim B, Kim H, Son SJ, Hong CH, Na DL, Kim HJ, Cho S, Won H, Seo SW. Ethnic differences in the frequency of β-amyloid deposition in cognitively normal individuals. Neurobiology of Aging 2022. [DOI: 10.1016/j.neurobiolaging.2022.03.001] [Reference Citation Analysis]
4 Seo Y, Jang H, Lee H. Potential Applications of Artificial Intelligence in Clinical Trials for Alzheimer’s Disease. Life 2022;12:275. [DOI: 10.3390/life12020275] [Reference Citation Analysis]